Enabling Technologies Sample Clauses

Enabling Technologies. The term “
Sample 1Sample 2
AutoNDA by SimpleDocs
Enabling Technologies. 2.2.2.2.1 Connected Vehicle Environment There are corridors and intersections in Columbus that have high crash numbers with vehicles, bicyclists and pedestrians. In addition, there are several corridors that are congested that result in poor mobility conditions for emergency vehicles, freight and transit buses. The CVE corridors were selected based on regional crash data, enhanced transit services, recent infrastructure investments and relationship to other projects. For example, the CVE corridors have 17 intersections in the top 100 regional high-crash intersections. The anticipated outcomes of the CVE project are to enhance safety and mobility throughout the city's transportation system utilizing CV technologies and applications with an emphasis on congested and high crash intersections and corridors. Safety applications are intended to be installed on multiple vehicle types including transit buses, first responder vehicles, city and partner fleet vehicles and private vehicles. Applications will be deployed to ensure emergency vehicles and the Central Ohio Transit Agency (XXXX) Bus Rapid Transit (BRT) fleet can utilize signal prioritization when needed to ensure safety and efficiency. While the CV applications the city plans to deploy will be identified as part of the planning phase of the systems engineering process, examples of strategies include: • Enhanced emergency vehicle pre-emption that reduces delays at signalized intersections for emergency vehicles responding to incidents and other emergencies • Transit signal priority that reduces delays at signalized intersections for transit vehicles helping to improve transit operations • Red-light safety applications for improved safety of pedestrians and drivers of vehicles at signalized intersections • School zone warnings that increase school zone visibility and alert drivers of posted speeds, helping to improve safety The Performance Measurement Plan establishes the measures and methods through which the goals and objectives of the CVE project will be evaluated to determine the project’s effectiveness of meeting the Smart Columbus vision and mission. The City of Columbus has identified the following preliminary objectives to evaluate the measurable impact the CVE project is intended to provide: • Reduce emergency response times • Improve motorist’s adherence to red lights • Improve adherence to speed limits in school zones • Improve reliability of transit vehicle schedule adherence • Reduce truck wait...
Sample 1
Enabling Technologies. Upon Corbis' acceptance of the final version of the site and payment to Busy Box of the full amount of the Master Agreement Fee and the Fee for work performed under this Revised Agreement, Busy Box shall irrevocably grant Corbis,
Sample 1
Enabling Technologies. Any technologies that may be necessary to make or use any product or portion thereof that complies with a Final Specification but are not them- selves expressly set forth in a Final Specification (e.g., semiconductor manufacturing technology, compiler technology, object oriented technology, basic operating system technology or the like)
Sample 1
Enabling Technologies. Infrastructure components in the topsectors Dutch Techcentre for Life Sciences (DTL) The Dutch Techcentre for Life sciences (DTL) is founded by - and builds on - six national scientific centers with a strong technological basis in: (i) next generation sequencing (Centre for Genome Diagnostics), (ii) proteomics (Netherlands Proteomics Centre), (iii) metabolomics (Netherlands Metabolomics Centre), (iv) advanced microscopy (NL-BioImaging AM), (v) bioinformatics (Netherlands Bioinformatics Centre), and (vi) systems biology (Netherlands Consortium for Systems Biology). DTL builds on best practices and expertise developed in these centers of expertise. DTL makes widely available high-end enabling technologies (expertise, services, equipment and training) in the life sciences in general and in the field of health-related R&D of academia and industry in particular. DTL expertise and infrastructure is accessible for research institutes, hospitals and industry, with a specific proposition towards SMEs. DTL encompasses a broad network of expertise and facilities that is already involved in major public-private life science programs, and therein well-connected with over 70 SMEs and large companies. DTL combines its technology portfolio around the functional and structural molecular organization of living systems. It has the capacity to integrate the analysis at the DNA/RNA level with subsequent levels of molecular organization and regulation Regiegroep Life Sciences & Health (proteins, metabolites, supra-molecular (and cellular) structures). DTL thus offers integrated technological approaches in next generation sequencing (NGS), proteomics, metabolomics and advanced microscopy, and includes bioinformatics and systems biology to streamline the analysis, integration and stewardship of life science data. DTL develops dedicated technology applications for industry and academia, responding to the needs of the healthcare system as detailed in the LS&H topsector roadmaps. Of course, novel technologies will emerge in the international fields to complement (or replace) the high-end technologies of today. DTL includes an active policy to continuously scout, develop and select emerging technologies that fit in the DTL portfolio. With a primary selection of the international (scientific) quality of the associated community, selected new technologies must have a strong potential within the LS&H and other topsectors, and be able to adopt the DTL strategy to set up enabling technolo...
Sample 1

Related to Enabling Technologies

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • New Technology When new or updated technology is introduced into a workplace, it will be the responsibility of the employer to provide appropriate and, if necessary, ongoing training to the employees directly affected. Such training will include any health and safety implications or information that will enable employees to operate the equipment without discomfort and will help maintain their general well-being.

  • EMERGING TECHNOLOGIES The State reserves the right to modify the terms of this Contract or any future Periodic Recruitments, to allow for emerging technologies. OGS reserves the right to include such technology(ies) hereunder or to issue a formal modification or amendment to this Contract.

  • Technology Upgrades Notwithstanding any other provision of this Agreement, Verizon shall have the right to deploy, upgrade, migrate and maintain its network at its discretion. The Parties acknowledge that Verizon, at its election, may deploy fiber throughout its network and that such fiber deployment may inhibit or facilitate PNG’s ability to provide service using certain technologies. Nothing in this Agreement shall limit Verizon's ability to modify its network through the incorporation of new equipment or software or otherwise. PNG shall be solely responsible for the cost and activities associated with accommodating such changes in its own network.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • INTELLECTUAL PROPERTY RIGHTS - INVENTION AND PATENT RIGHTS Unless otherwise agreed upon by NASA and AFRL, custody and administration of inventions made (conceived or first actually reduced to practice) under this IAA will remain with the respective inventing Party. In the event an invention is made jointly by employees of the Parties (including by employees of a Party's contractors or subcontractors for which the U.S. Government has ownership), the Parties will consult and agree as to future actions toward establishment of patent protection for the invention.

  • Licensed Technology The term “Licensed Technology” shall mean the Licensed Patent Rights, Licensed Know-How and Licensed Biological Materials.

  • Third Party Technology Customer is hereby notified that third parties have licensed certain technology to Company, which is contained in the Software. Notwithstanding anything herein to the contrary, Customer hereby consents to the disclosure of Customer’s identity, and such other terms of this Agreement as necessary, to such third party licensors for the purpose of enabling Company to comply with the terms and conditions of such third party licenses. Any such Customer information will be provided pursuant to an obligation of confidentiality and nondisclosure at least as stringent as that imposed by this Agreement.

  • Security Technology When the service is accessed using a supported web browser, Secure Socket Layer (“SSL”), or equivalent technology shall be employed to protect data from unauthorized access. The service security measures shall include server authentication and data encryption. Provider shall host data pursuant to the DPA in an environment using a firewall that is periodically updated according to industry standards.

Time is Money Join Law Insider Premium to draft better contracts faster.